drugset / Trial / NCT02359474
Hyper-Thermia Enhanced Anti-tumor Efficacy of Trabectedin
RandomizedSingle-groupOpen-labelTreatment
Summary
This trial compares trabectedin alone to trabectedin in combination with regional hyperthermia in patients with high-risk soft tissue sarcoma. The study is designed to demonstrate a significant benefit for sarcoma-therapy by adding regional hyperthermia.
Timeline
- Start
- 2014-12-19
- Primary completion
- 2023-08
- Completion
- 2023-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trabectedin | Small molecule | 1.5 mg/m2 | Intravenous |